News & Media

16 May 2019

Member Consultation: Guideline on the use of Gadolinium-containing MRI Contrast Agents in Patients with Renal Impairment

The Guideline on the use of Gadolinium-containing MRI Contrast agents in patients with Renal Impairment has been developed by the College’s Standards of Practice and Accreditation Committee’s MRI Reference Group, in consultation with the Dialysis, Nephrology and Transplant Sub-committee of the Australian and New Zealand Society of Nephrology. It is designed to provide guidance to radiologists on the safe and effective use of contrast agents used to enhance Magnetic Resonance Imaging examinations.

Members and interested parties can submit their comments and feedback to This email address is being protected from spambots. You need JavaScript enabled to view it. by COB Friday, 28 June 2019.

 

Please click here to read the full consultation.